Consequences of intratumoral injection of a herbal preparation containing bloodroot (Sanguinaria canadensis) extract in two dogs

Journal of the American Veterinary Medical Association

Volumn 239, Issue 3, 2011, Pages 374-379

  Childress, Michael O ^a   Burgess, Richard C F ^a   Holland, Christine H ^a   Gelb, Hylton R ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLANT EXTRACT;

ANIMAL; ANIMAL DISEASE; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DOG; DOG DISEASE; FEMALE; MALE; NEOPLASM; PATHOLOGY; POSTOPERATIVE COMPLICATION; SANGUINARIA;

ANIMALS; DOG DISEASES; DOGS; FEMALE; MALE; NEOPLASMS; PLANT EXTRACTS; POSTOPERATIVE COMPLICATIONS; SANGUINARIA;

ANIMALIA; CANIS FAMILIARIS; SANGUINARIA; SANGUINARIA CANADENSIS;

EID: 79961064151     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.239.3.374     Document Type: Article

References (33)

1. Jellinek N, Maloney ME. Escharotic and other botanical agents for the treatment of skin cancers: a review. J Am Acad Dermatol 2005;53:487-495.
2. McDaniel S, Goldman GD. Consequences of using escharotic agents as primary treatment for nonmelanoma skin cancer. A rc h Dermatol 2002;138:1593-1596.
3. Mohs FE. Chemosurgery: microscopically controlled method of cancer excision. Arch Surg 1941;42:279-295.
4. Fox TS. Discussion of and clinical guide for the treatment of neoplasm, proud fesh, and warts with sanguinarine and related iso-quinoline alkaloids. Available at: www.buckmountainbotanicals. net/about/. Accessed Apr 19, 2010.
5. Tin-Wa M, Farnsworth NR, Fong HHS, et al. Biological and phy-tochemical evaluation of plants. 8. Isolation of a new alkaloid from Sanguinaria canadensis. Lloydia 1970;33:267-269.
6. Malikova J, Zdarilova A, Hlobilkova A. Effects of sanguinarine and chelerythrine on the cell cycle and apoptosis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2006;150:5-12.
7. Adhami VM, Aziz MH, Reagan-Shaw SR, et al. Sanguinarine causes cell cycle blockade and apoptosis of human prostate carcinoma cells via modulation of cyclin kinase inhibitor-cyclin-cyclin-dependent kinase machinery. Mol Cancer Ther 2004;3:933-940.
8. Chaturvedi MM, Kumar A, Darnay B, et al. Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-κB activation, IκBα phosphorylation, and degradation. J Biol Chem 1997;272:30129-30134.
9. Ahmad N, Gupta S, Husain MM, et al. Differential antiprolif-erative and apoptotic response of sanguinarine for cancer cells versus normal cells. Clin Cancer Res 2000;6:1524-1528.
10. Théon A P, Wilson WD, Magdesian KG, et al. Long-term outcome associated with intratumoral chemotherapy with cisplatin for cutaneous tumors in equidae: 573 cases (1995-2004). J Am Vet Med Assoc 2007;230:1506-1513.
11. White SD, Yu AA. Equine dermatology, in Proceedings. 52nd Annu Conv Am Assoc Equine Pract 2006;457-500.
12. Saltzberg F, Barron G, Fenske N. Deforming self-treatment with herbal black salve. Dermatol Surg 2009;35:1152-1154.
13. Affeck AG, Varma S. A case of do-it-yourself Mohs' surgery using bloodroot obtained from the Internet. Br J Dermatol 2007;157:1078-1079.
14. Moran AM, Helm K F. Histopathologic fndings and diagnostic diffculties posed with use of escharotic agents for treatment of skin lesions: a case report and review of the literature. J Cutan Pathol 2008;35:404-406.
15. Osswald SS, Elston DM, Farley M F, et al. Self-treatment of a basal cell carcinoma with "black and yellow salve." J Am Acad Dermatol 2005;53:509-511.
16. Laub DR. Death from metastatic basal cell carcinoma: herbal remedy or just unlucky? J Plast Reconstr Aesthet Surg 2008;61:846-848.
17. Coussens LM, Werb Z. Infammation and cancer. Nature 2002;420:860-867.
18. Mascarenhas AK, Allen CM, Moeschberger ML. The association between Viadent and oral leukoplakia-results of a matched case-control study. J Public Health Dent 2002;62:158-162.
19. Sharma BD, Bhatia V, Rathee M, et al. Epidemic dropsy: observations on pathophysiology and clinical features during the Delhi epidemic of 1998. Trop Doct 2002;32:70-75.
20. +-ATPase. Eur J Pharmacol 1979;60:373-377.
21. Richardson MA, Sanders T, Palmer JL, et al. Complementary/ alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000;18:2505-2514.
22. Eisenberg DM, Kessler RC, Foster C, et al. Unconventional medicine in the United States: prevalence, costs, and patterns of use. N Engl J Med 1993;328:246-252.
23. Lana SE, Kogan LR, Crump KA, et al. The use of complementary and alternative therapies in dogs and cats with cancer. J Am Anim Hosp Assoc 2006;42:361-365.
24. Robinson NG. Complementary and alternative medicine for patients with cancer. In: Withrow SJ, Vail DM, eds. Small animal clinical oncology. 4th ed. St Louis: Saunders-Elsevier, 2007;1126-1132.
25. Fetrow CH, Avila JR. Professional's handbook of complementary and alternative medicines. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2003.
26. Sparreboom A, Cox MC, Acharya MR, et al. Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol 2004;22:2489-2503.
27. Priester WA. Skin tumors in domestic animals. Data from 12 United States and Canadian colleges of veterinary medicine. J Natl Cancer Inst 1973;50:457-466.
28. Brodey RS. Canine and feline neoplasia. Adv Vet Sci Comp Med 1970;14:309-354.
29. Miller MA, Nelson SL, Turk JR, et al. Cutaneous neoplasia in 340 cats. Vet Pathol 1991;28:389-395.
30. Murray DR, Ladds P W, Campbell RSF. Granulomatous and neo-plastic diseases of the skin of horses. Aust Ve t J 1978;54:338-341.
31. Baker JR, Leyland A. Histological survey of tumors of the horse, with particular reference to those of the skin. Vet Rec 1975;96:419-422.
32. Mohs FE. Chemosurgical treatment of cancer of the skin: a microscopically controlled method of excision. J Am Med Assoc 1948;138:564-569.
33. Electronic Freedom of Information reading room. US FDA. Available at: www.fda.gov/foi/warning.htm. Accessed Dec 7, 2009.